Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Evaporation Chemistry at ACS

Published: Monday, August 19, 2013
Last Updated: Monday, August 19, 2013
Bookmark and Share
Genevac to display its latest products for productive evaporation in USA.

Genevac has announced that it will display its latest products for productive evaporation at the 246th American Chemical Society meeting and exposition in Indianapolis, Indiana, USA (8th - 12th September 2013).Genevac_PN.gif

Visitors to Booth 2017 will have the chance to see for the first time the ROCKET 4D - a new fully automated system for drying or concentration of very large volumes (a few to 100 litres) in one operation with no user interaction.

Simply load sample, select a method, press start, and walk away - the system will do the rest.

Compact in size the ROCKET 4D allows users to safely dry or concentrate their samples with complete confidence as it uses proprietary vacuum technology to suppress solvent bumping and foaming - problems associated with sample loss when using large scale rotary evaporators.

To download a ROCKET 4D technical brochure, please visit www.genevac.com/Rocket4D.

Specialists will also be on hand to demonstrate and discuss the third generation EZ-2 Series Evaporator - an easy-to-use benchtop system that uses the most advanced proven technology in evaporation science.

The EZ-2 accurately controls vacuum and temperature to enable rapid evaporation of a wide range of solvents and prevent bumping and cross contamination.

Compatible with a wide range of sample holders the EZ-2 will easily integrate within the workflow of many laboratories. Options are available to enable routine, safe removal of potentially explosive solvents such as diethyl ether or pentane and also removal of acids including concentrated hydrochloric acid (HCl).

To download an EZ-2 technical brochure, watch a product video or download applications reports please visit - www.genevac.com/movie/ez2.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Structure of Cold Virus Solved
Researchers have identified the structure of an elusive cold virus linked to child asthma and respiratory infections, providing the foundation for treating the virus.
'Poison Pill' Fed to Deadly Virus
Researchers have created a genetic modification within a virus (with funny name), rendering it unable to replicate, mutate or cause illness.
World First Alzheimer's Vaccine Breakthrough
Researchers have made a breakthrough discovery towards an effective vaccine for Alzheimer's by targeting associated proteins.
Immunotherapy Drug Combo Targets Cancer
Mayo Clinic researchers identify potential immunotherapy drug combination that shows therapeutic effects against advanced and metastatic cancers.
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
New data shows Sandoz biosimilar candidate has equivalent efficacy to originator etanercept following comparison in psoriasis.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Immunotherapy Reduces Rheumatoid-Linked Cardiovascular Risk
Study shows combination of two extra-low dose anticytokines reduces disease activity and cardiovascular events.
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
Sanofi Working on Zika Vaccine with U.S. Army
Sanofi is working in conjunction with the U.S. Army to develop possible Zika vaccine at faster rate following research agreement.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!